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Abstract. Oligonucleotide-directed mutagenesis of a 
cDNA encoding the hemagglutinin of influenza virus 
has been used to introduce single base changes into 
the sequence that codes for the conserved apolar 
"fusion peptide" at the amino-terminus of the HA2 
subunit. The mutant sequences replaced the wild-type 
gene in SV40-HA recombinant virus vectors, and the 
altered HA proteins were expressed in simian cells. 
Three mutants have been constructed that introduce 
single, nonconservative amino acid changes in the 
fusion peptide, and three fusion phenotypes were ob- 
served: substitution of glutamic acid for the glycine 
residue at the amino-terminus of HA2 abolished all 
fusion activity; substitution ofglutamic acid for the 
glycine residue at position 4 in HA2 raised the thresh- 
old pH and decreased the efficiency of fusion; and, 
finally, extension of the hydrophobic stretch by re- 
placement of the glutamic acid at position 11 with 
glycine yielded a mutant protein that induced fusion 
of erythrocytes with cells with the same efficiency and 
pH profile as the wild-type protein. However, the abil- 
ity of this mutant to induce polykaryon formation was 
greatly impaired. Nevertheless, all the mutant proteins 
underwent a pH-dependent conformational change 
and bound to liposomes. These results are discussed in 
terms of the mechanism of HA-induced membrane 
fusion. 
T 
HE reactions that mediate fusion by enveloped animal 
viruses are catalyzed by specific viral membrane pro- 
teins (for review see reference  49). Of these,  the best 
characterized is the hemagglutinin (HA) ~ of influenza virus. 
HA, which is the major glycoprotein of the virus envelope,  is 
responsible  for the attachment of the virion to sialic acid- 
containing receptors  on the host cell surface  (15) and also 
undergoes a  low pH-induced  conformational change that 
initiates the fusion of the virus envelope with the endosome 
membrane (5,  16,  25,  28,  29,  44,  50). This fusion activity 
requires  that the HA be anchored into a lipid bilayer via a 
hydrophobic, transmembrane segment near the carboxy'-ter- 
minus of the molecule (48). Furthermore, the protein must 
be processed by a posttranslational proteolytic cleavage of the 
hemagglutinin precursor,  HA0, into the active  form of the 
molecule, HA, which consists  of two disulfide bonded sub- 
units,  HA1  and  HA2  (17,  19,  22,  23,  50). This cleavage 
generates on the HA2 subunit a  new hydrophobic amino- 
terminus, the "fusion peptide," which is highly conserved in 
' Abbreviations  used in this paper."  BHA, bromelain-released fragment of HA: 
DAB, diaminobenzidine: DME,  Dulbecco's modified Eagle's medium; HA, 
hemagglutinin" HRP. horseradish peroxidase;  RBC, red blood cell. 
HAs from different influenza virus strains (reviewed in refer- 
ence 21) and which has been implicated in participating in 
the fusion activity (8,  11, 35, 44,  51). x-ray crystallographic 
studies (51) have shown that the HA molecule in its neutral 
form is a trimer that projects from the viral envelope as a rod- 
shaped structure 135 A long. The hydrophobic fusion peptide 
in each monomer is tucked into the interface between the 
subunits of the trimer, -30 ,~ from where the protein inserts 
into the lipid bilayer of the  virus  envelope or the plasma 
membrane. It has been proposed (3-5, 44, 48) that below the 
threshold  pH  for fusion, the  protonation of one  or  more 
amino acid side chains causes a partial dissociation of  the HA 
trimer, exposing the fusion peptide which then inserts  into 
the target bilayer.  HA would then become an integral com- 
ponent of both the viral and target membranes, presumably 
bringing them close enough together to fuse. 
The fusion activity of HA can be manifested experimentally 
as cell-cell fusion when monolayers of cells displaying HA on 
their plasma membranes are transiently exposed to low pH 
( 16, 25, 48, 50). Alternatively, fusion activity can be measured 
quantitatively by red blood cell (RBC)-mediated delivery of 
horseradish peroxidase  (HRP) into cells that express surface 
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ent influenza viruses have shown that HA-induced cell fusion 
displays a  characteristic pH profile, with  the threshold  pH 
varying between 5 and 6 depending on the viral origin of the 
HA molecule (16,  49).  To confirm the central role of HA in 
the  fusion  mechanism,  we  have  previously used  cells  that 
express HA from a cloned copy of the HA gene inserted into 
recombinant SV40 or BPV vectors to demonstrate that the 
HA molecule displays fusion activity in the absence of any 
other influenza virus-encoded components (39, 48).  The HA 
undergoes a  conformational change with a  pH dependence 
that parallels that of the fusion activity (5, 44).  This confor- 
mational change can be monitored by following the acquisi- 
tion of protease sensitivity by an ectodomain fragment of HA 
(BHA) released from the membrane by treatment with bro- 
melain (2) and by the ability of this fragment to bind to lipid 
vesicles or detergents or to aggregate in lipid- or detergent- 
free solutions (5, 44). 
Two genetic approaches are currently being employed to 
analyze the mechanism of HA-mediated fusion and to identify 
particular amino acids in HA that are directly involved in the 
fusion  process.  The  first involves detection  or  selection  of 
variant viruses that induce fusion with raised pH thresholds. 
Sequence analysis of the HA from each variant locates altered 
residues that play a role in the pH dependence of fusion (4, 
5a,  38).  The second approach, illustrated  in this paper,  in- 
volves the use of site-specific mutagenesis of the cloned HA 
gene to alter the nucleotide sequence that codes for selected 
residues of the fusion peptide in the amino-terminus of HA2. 
Expression of the mutant genes in simian cells has confirmed 
the central role of the fusion peptide and provided insights 
into the fusion mechanism. 
Materials and Methods 
Recombinant DNA Techniques 
Oligonucleotides were synthesized using phosphotriester chemistry on a  Bio- 
search Synthesizer (Biosearch, San Rafael, CA). Buffers and reaction conditions 
for restriction enzymes, T4  DNA  ligase, and the Klenow fragment of DNA 
polymerase I were those listed by the commercial source, New England Biolabs 
(Beverly, MA). Isolation of DNA fragments and preparation of plasmid DNAs 
were  carried  out  as  described  by  Maniatis et  al.  (26).  Transformation  of 
Escherichia  coli  strain  DH-I  was  carried  out  according to  Hanahan  (13). 
Transfection of E. coli strain TG-1  with M I3 phage DNA, infection of TG-1 
cells with M 13 phage virions, and purification of single- and double-stranded 
forms of M 13 phage DNA were carried out as described by Zoller and Smith 
(55). 
Site-specific Mutagenesis of  HAcDNA Using 
Mismatched Oligonucleotides 
Plasmid pJHBI6 that contains a full length cDNA copy of the HA gene from 
influenza virus strain A/Japan/305/57 (10) was digested with EcoRI restriction 
endonuclease, and a 504-bp DNA fragment (nucleotides 764-1,268 of the HA 
gene) that includes sequences encoding the HA fusion peptide was purified by 
gel  electrophoresis.  This  fragment was inserted  into  the  EcoRl  site  of the 
double-stranded replicative form of Ml3mpll  phage DNA, and E. coli TGI 
cells were transfected with the ligated DNA molecules. A  recombinant phage 
(mpl 1.RI-HA) was selected in which the single-stranded DNA purified from 
MI3  virions secreted from  infected bacterial cells contained the  noncoding 
complementary sequences of HA cDNA. Three  16-mer oligonucleotides that 
corresponded, except for a single mismatch, to sequences encoding regions of 
the fusion peptide (Fig.  1) were used to introduce base substitutions into the 
HA gene fragment. The procedures used to carry out oligonucleotide-directed 
mutagenesis and identification of the desired mutants have been described in 
detail by Zoller and Smith (53-55).  In brief, the 5'-termini of the mutagenic 
oligonucleotides  were phosphorylated by treatment with polynucleotide kinase 
(P-L Biochemicals, Inc., Milwaukee, WI) using either excess unlabeled ATP 
(for mutagenesis reactions) or [~2p]ATP (for hybridization probes). Mutant M I 
was introduced using the original single primer mutagenesis procedure (53, 54). 
The kinased mutagenic M 1 oligonucleotide was used to prime synthesis on the 
single-stranded mplI.RI-HA  DNA  template using the  Klenow fragment of 
DNA polymerase 1.  T4 DNA  ligasc was included in the reaction mixture to 
promote  the  formation  of closed double-stranded  DNA  circles which were 
purified by centrifugation through an alkaline sucrose gradient before transfec- 
tion of competent TG-I  cells (13). Subsequent mutagenesis experiments used 
a  modified procedure (Fig. 2) that employs two oligonucleotide primers (55). 
Single-stranded  M I3  template  was  annealed  with  the  appropriate  kinased 
mutagenic oligonucleotide, together with the  MI3  17-mer universal primer. 
The primers were extended using the Klenow fragment of DNA polymerase I 
in the presence of T4 DNA ligase. Competent TG-I cells were transfected with 
an aliquot of the reaction mixture which contained partially- and fully double- 
stranded DNA  molecules. Following either procedure, plaques of phage that 
contained mutant HA sequences were identified by hybridizing phage DNA 
adsorbed onto nitrocellulose circles with 32p-labeled mutagenic oligonucleotide 
and then washing the filters at increasing temperatures until the oligonucleotide 
dissociated from wild-type DNA but remained bound to mutant DNA. Phages 
that showed positive hybridization (e.g.,  see Fig. 2) were plaque purified, and 
single-stranded DNA was purified for use as template for sequence analysis by 
the technique of chain termination (40,  41) using the HA sequence primer 
shown in Fig.  1. To construct the double mutants, single-stranded DNA from 
the M 11 mutant was used as template for further mutagenesis using the M 1 or 
M4  oligonucleotides. Once  the desired base  substitution(s) was (were) con- 
firmed, the double-stranded replicative form of each mutant phage DNA was 
prepared and'purified by centrifugation on CsC12 gradients. 
Reconstruction  of SV40-HA Recombinant Genomes 
Containing Mutant HA Sequences 
As shown in Fig. 2, the double-stranded phage DNAs were digested with EcoRl 
and the 504-bp RI fragments containing mutant HA sequences were purified 
by gel electrophoresis. EcoRl digestion was also performed on pRI-SVEHA3, 
a  recombinant  SV40-HA  genome  that  contains  full-length,  wild-type  HA 
sequences and differs only from the vector previously described (7, 9) in being 
cloned through the unique Bam HI site into plasmid pJC2 (a gift of J. Jenkins 
and A. Cowie, Imperial Cancer Research Fund, London) that lacks an EcoRl 
site.  Gel  electrophoresis was used  to  purify  the  large EcoRI  fragment  that 
contained the SV40 and plasmid sequences and the HA sequences except for 
the  504-bp  restriction fragment. This fragment was ligated with the various 
small EcoRl fragments containing the mutant sequences, and the recircularized 
SV40-HA  plasmid  was  used  to  transform  E.  coil  DH-I.  Bacterial  clones 
harboring plasmids that contained the 504-bp sequence were identified by the 
Grunstein-Hogness technique (12) using the wild-type EcoRI fragment labeled 
by nick-translation (27) as hybridization probe. Finally, plasmids  that contained 
the EcoRl fragment in the correct orientation that maintained the HA reading 
frame were identified by analysis using agarose gel electrophoresis of restriction 
fragments generated  by  digestion with  Xmnl  restriction endonuclease.  To 
confirm that the various SV40-HA recombinant genomes contained the desired 
mutations,  the  504-bp  EcoRI  fragments  were  excised,  and  recloned  into 
Ml3mpl 1,  and  sequence analysis was performed  by the chain termination 
procedure (40, 41) using the HA sequence primer. 
Generation of  SV40-HA Virus Stocks and Infection of 
Simian CV-1 Cells 
50  #g  plasmid  DNA  was  digested  with  BamHl  and  the  larger  fragment, 
corresponding to the SV40-mutant HA recombinant genome, was isolated by 
agarose gel electrophoresis, recircularized under dilute ligation conditions (3 
ug/ml), and transfected into subconfluent monolayers of CV-I  cells together 
with  an  equal  amount  of  DNA  from  the  helper  virus  d11055  (32).  The 
procedures used for the transfection and development of high titer virus stocks 
were exactly as previously described (7).  CV-I  cells were grown in Dulbecco's 
modified Eagle's medium (DME) supplemented with 10% fetal calf  serum, 250 
U/ml penicillin, and  100 ug/ml streptomycin sulfate. For assay, slightly sub- 
confluent monolayers of CV-I cells were infected with the SV40-HA recombi- 
nant viruses containing either wild-type or mutant HA genes. Second passage 
virus stocks were used at a  1/10 dilution in DME (0.3 ml per 5-cm dish of cells 
or 0.1  ml per well in  12-well  Costar cluster plates; Costar, Cambridge, MA). 
After  1.5 h at 37°C, DME plus  10%  fetal calf serum was added and the cells 
were incubated for 36-60 hr before assays were performed. 
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Figure  1.  Oligonucleotide-directed  mutagenesis  of the fusion peptide of HA. A linear diagram of the HA molecule shows the three hydrophobic 
domains of the protein as cross-hatched regions. The amino acid sequence and the encoding nucleic acid sequence are displayed for the region 
of HA that includes the fusion peptide. The mismatched oligonucleotides that were chosen to introduce specific amino acid changes in this 
region are shown, together with the matched oligonucleotide  that was used as primer for DNA sequence analysis (see Materials and Methods). 
Characterization of Wild-type and Mutant HAs 
Expressed in CV-1 Cells 
To  quantitate the amount  of HA  protein produced  from  the  recombinant 
genomes, cell extracts were prepared 48 and 60 h after infection,  and radioim- 
munoassays were performed as described  previously (9) using an lgG fraction 
purified from a high-titer  rabbit anti-HA serum. Standard curves were generated 
using HA that had been purified to homogeneity from A/Japan/305/57 virions 
adn whose concentration had been determined by amino acid analysis (Cope- 
land, C., unpublished results). To compare the size of the wild-type and mutant 
HAs,  infected  cell  monolayers  (36  h  after  infection)  were  labeled  with 
[3SS]methionine (50 #Ci per 5-cm dish) for  15 min at 37"C. The monolayers 
were then washed once with Tris-saline  solution, and cell extracts  were prepared 
in 50 mM Tris-HCI,  pH 8.0, containing 1% Nonidet P-40.  Alternatively, the 
labeled cells were washed twice in medium containing nonradioactive methio- 
nine,  and the incubation was continued for  2 h  at 37"C before  cell extracts 
were prepared.  To analyze the proportion of HA that was displayed on the cell 
surface, trypsin (10 ug/ml) was included in the medium for the last 15 min of 
the chase period.  To compare the sizes of the nonglycosylated HA molecules, 
infected  monolayers were  treated with tunicamycin (4  #g/ml; Calbioehem- 
Behring Corp.,  San  Diego,  CA)  for  2  h  before  labeling for  15  min  with- 
[3SS]methionine in the presence  of tunicamycin. Aliquots of the cell extracts 
were immunoprecipitated using anti-HA serum, and the products were sepa- 
rated by SDS PAGE as described previously (9). 
HA Assays 
Infected  cell monolayers were incubated with guinea pig or human RBCs (a 
1% solution in phosphate-buffered  saline [PBS]) for  15 min at room tempera- 
ture. The monolayers  were then washed with PBS until all the loose erythrocytes 
were removed and examined by light microscopy. 
Cell-Cell Fusion Assays 
The capacity of CV-I cells infected with the various SV40-HA  viruses to fuse 
together to form polykaryons was assayed as previously described  (48). 54-60 
h after infection (when parallel cultures showed >90% RBC binding), the cells 
were  treated with 5 ug/ml trypsin to cleave HA0 into HAl  and  HA2.  The 
monolayers were then  treated for  60  s  at  37"C with fusion  medium (PBS 
containing 10 mM 2-(N-morpholino)ethane sulfonic acid and  10 mM Hepes 
adjusted to  the indicated pH  with HCI  or NaOH).  This solution was then 
removed and the cells were incubated for 5-8 h in tissue culture medium. At 
this time the cells were fixed in ice-cold methanol, stained with Giemsa, and 
observed  under the light microscope. 
RBC-Cell Fusion Assays 
The ability of HA-expressing ceils to fuse with RBCs was assayed as previously 
described  (6). In  brief,  48-54  h  after infection the cells were  trypsinized as 
above to cleave HA0 to the fusion-active  form.  The cells were then washed 
twice in PBS and allowed to bind for  15 min at room temperature to human 
RBCs previously loaded with horseradish  peroxidase (HRP).  Excess RBCs were 
aspirated, and 2 ml of fusion medium of the indicated pH (prewarmed to 37"C) 
was added to each well. After the cells had been treated for 60 s at 37"C the 
fusion solution was aspirated and the cells were incubated in culture medium 
for 45 rain in a CO2 incubator. Unless otherwise stated the cells were then fixed 
in 2.5 % glutaraldehyde  and stained with diaminobenzidine  (DAB) as previously 
described  (6). The coverslips were mounted and viewed by light microscopy. 
The percentage of DAB-positive  cells was then determined by scoring at least 
four fields per coverslip; each field contained ~ 100 cells. 
To  quantitate the  fusion  of CV-I  cells with  loaded  erythrocytes more 
rigorously,  unfixed  cells were  treated  for  30  rain  at  37"C  with  15  mg/ml 
neuraminidase to remove RBCs that were bound but not fused to the CV-I 
cells. Cell extracts were then prepared with Nonidet P-40 and assayed for HRP 
activity  by the method of Steinman and Cohn (45). 
Preparation of BHA Fragment  from CV-1 Cells 
Infected with SV40-HA  Vectors 
48 h after infection with SV40-HA vectors containing  wild-type or mutant HA 
genes,  10-cm  dishes of CV-I  ceils were  washed  with PBS  and  placed into 
methionine-free medium supplemented with 0.5  mCi [3SS]methionine. After 
they were labeled overnight, the cells were washed twice with PBS and lysed 
with  1 ml  of  1%  Triton  X-100  in  0.1  M  Tris-HCl,  pH  8.0,  and  1 mM 
phenylmethylsulfonyl  chloride  and 1 mM aprotinin (both from Sigma Chemical 
C~., St. Louis, MO). The lysate was digested with 0.1  mg/ml bromelain for 16 
hat  room  temperature in the presence  of 20  mM  2-mercaptoethanol. The 
digestion was stopped by the addition of 1 mM N-ethylmaleimide, and the 
lysate was passed over a ricin-Sepharose  affinity  column as previously  described 
(5).  The  bound  material, most of which was BHA,  was eluted with 0.2  M 
galactose, concentrated in an Amicon ultrafiltration  cell (XM50 filter, Amicon 
Corp.,  Danvers,  MA), and run on a 5-25% continuous sucrose gradient (wt/ 
vol in PBS) in an SW-40 rotor (Beckman Instruments Inc., Palo Alto, CA) at 
40,000  rpm for  16 h at 20"C. The gradients were fractionated and assayed for 
radioactivity, and the peak fractions were stored  at 4*C. The BHA molecules 
produced in this manner were trimeric as judged by their position on sucrose 
gradients as 9S peaks (2); all preparations were >90% pure by examination on 
SDS PAGE. 
Lipid-binding Assays 
Liposomes were freshly prepared before each experiment as described  previ- 
ously  (47)  and  contained  phosphatidylcholine, phosphatidylethanolamine, 
sphingomyelin,  cholesterol, and phosphatidic acid (all from Avanti Polar Lipids 
Inc., Birmingham, AL) in a  1:1:1:5:0.3 molar ratio. Trace amounts of 3SS-BHA 
(-15,000  cpm)  in  10  #1  were  added  to  90  ~1  of liposomes (4.5  mM  in 
phospholipid).  The solution was incubated at 37°C. and the pH was adjusted 
13  Gething et al. Mutagenesis of the Fusion Peptide of  HA Figure  2.  Construction of SV40-HA vectors containing mutant HA genes. The EcoRI  restriction fragment of the Japan  HA gene (10) was 
cloned into M l3mpl 1 phage DNA, and the single stranded virion RNA was used as template for mutagenesis by the double primer method 
(55)  using each  of the  mismatched oligonucleotides shown  in  Fig.  1.  Phage plaques containing mutant  HA  sequences were  identified  by 
hybridization with 32p-labeled oligonucleotide. The EcoRI restriction fragments containing the mutant sequences were excised from the double- 
stranded  replicative  form  of the phage  DNAs and  used to  replace  the equivalent wild-type  sequences in  the  SVEHA3  vector.  RT,  room 
temperature. SS-DNA and DS-DNA, single- and double stranded DNA, respectively). Details are given in Materials and Methods. 
by the addition of pretitrated volumes of 0.5 M acetic  acid.  After 30 min at 
37"C, the solution was neutralized with NaOH and 100 ul of 67% sucrose was 
added  to  bring the  final  sucrose concentration to  33%.  This solution was 
overlaid  with 300 ~tl of 25%  sucrose and 200 ul of 10%  sucrose in a  700-ul 
clear  ultracentrifuge tube (Beckman Instruments Inc.).  All sucrose solutions 
were wt/vol in 20 mM 2-(N-morpholino)ethane sulfonic acid,  130 mM NaCI, 
oH 7.0 unless otherwise stated. After centrifugation at 200,000 g for 3 h, 7 x 
100 ul fractions were collected  and counted for ~2~I. Counts in the top half of 
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were defined as unbound (5). 
Proteinase K Digestions 
BHA was incubated with liposomes as described above. After neutralization, 
an equal volume of 0.2 mg/ml proteinase K (Worthington Biochemical Corp., 
Freehold, N J) in PBS containing 0.5 mM CaCI2 and 0.5 mM MgCI2 was added. 
The digestion was allowed to proceed for 30 min at 37"C, pH 7.4, and was then 
terminated by the addition of 200 ul of ice-cold 20% trichloroacetic  acid (TCA). 
The TCA-precipitable material was washed with cold acetone to remove lipid 
and was prepared for SDS PAGE by solubilization in 50 tal Laemmli sample 
buffer. Alicluots were counted for the content of 35S-labeled protein. 
Results 
Construction of SV40-HA Recombinant  Virus Vectors 
That Express Mutant HA Proteins 
The hydrophobic "fusion peptide" at the amino-terminus of 
the HA2 subunit is the most highly conserved region of the 
HA molecule, suggesting that it plays a  critical  role in the 
infectious cycle of influenza. To confirm a direct role for this 
sequence in the fusion activity and to probe the mechanism 
of HA-mediated membrane fusion, we have used oligonucle- 
otide-directed mutagenesis to engineer mutant HA proteins 
with  specific  nonconservative  amino  acid  changes  in  the 
fusion peptide. These amino acid alterations were achieved 
by introducing  single  nucleotide  alterations  into  the  DNA 
sequence  that  encodes  the  fusion  peptide  (Fig.  1).  Three 
oligonucleotides were designed, synthesized using phosphate 
triester chemistry, and used to introduce single mutations in 
HA sequences that had been cloned into an M 13 vector (see 
Figs.  1 and 2 and Materials and Methods for a description of 
the mutagenesis procedures). To construct the double muta- 
tions  the  M1  and  M4  alterations  were  introduced  on  the 
background of the M 11  mutant gene. Once the presence of 
the desired mutations had been confirmed by DNA sequence 
analysis,  restriction  fragments  containing  each  altered  se- 
quence were used to replace wild-type sequences in an SV40- 
HA recombinant virus vector. High-titer virus stocks contain- 
ing the recombinant genomes were developed and  used  to 
infect simian CV-1 cells for expression of the wild-type and 
mutant HA proteins (see  references 7  and  9  and  Materials 
and Methods). 
Synthesis and Cell Surface Expression of Wild-type 
and Mutant HAs 
Before analyzing the  fusion  phenotype  of the  mutant  HA 
proteins, we performed experiments to characterize the HA 
molecules and to ensure that the  mutants were not grossly 
altered in their structure or level of expression. The amounts 
of  HA antigen present in CV- 1 cells at late times after infection 
with the mutant and wild-type SV40-HA recombinant viruses 
were quantitated by solid-phase radioimmunoassay. All mu- 
tants produced amounts of HA comparable to that expressed 
from the original SVEHA3  (wild-type) recombinant vector, 
i.e.,  -10  s molecules per infected cell at 60 h  after infection 
(9).  To characterize further the mutant  HAs,  infected cells 
were labeled with [3SS]methionine  for 15 min and then incu- 
bated  for 2  h  more to  allow expression  of the  terminally 
glycosylated proteins on the cell surface. Since the species of 
HA produced in CV-1 cells is the uncleaved HA0 (9,  48) it 
was possible to estimate the amount of HA that had reached 
the plasma membrane. Intact monolayers of labeled, infected 
cells were treated with trypsin to cleave HA0 into HAl and 
HA2 subunits before cell extracts were prepared, immunopre- 
cipitated, and analyzed by electrophoresis through SDS poly- 
acrylamide gels. The results shown in Fig. 3 confirm that the 
wild-type and  mutant  HAs were  expressed at  very similar 
levels and indicate that the mutant proteins were transported 
to the cell surface with the same efficiency as the wild-type. 
Hemagglutination of RBCs to the surfaces of infected cells 
provided further evidence of efficient cell surface expression. 
Approximately 48 h after infection with wild-type or mutant 
viruses, >95%  of the CV-I cells displayed binding of eryth- 
rocytes (see Fig. 5). 
Structural Comparison of Wild-type and Mutant 
HA Proteins 
Further evidence that the site-specific mutagenesis of HA had 
caused no gross alterations in the protein structure was pro- 
vided by the fact that all the mutant proteins were recognized 
by a panel of monoclonal antibodies directed against the A/ 
Japan/305/57  HA and  a  closely related  HA  from the  H2 
virus subtype A/Guiyang/1/57 (52).  In particular, all of the 
mutant  HAs were  precipitated  by two  of the  monoclonal 
antibodies that recognize native HA but do not recognize the 
denatured molecule (results not shown). Furthermore, soluble 
BHA fragments prepared from cells expressing the  mutant 
proteins migrated on sucrose gradients with the mobility (9S) 
characteristic  of the  native  trimeric  ectodomain  (data  not 
shown). Finally, the mutant BHAs all displayed similar resist- 
ance to proteolytic degradation at neutral pH, a criterion for 
the intact structure (see Fig. 7). 
Although the HA0 and HAl  bands of all the proteins had 
very similar or identical  mobilities,  minor differences were 
detected in the mobilities of the HA2 bands. The magnitude 
of these differences varied from experiment to experiment, 
with the maximum deviation from the mobility of the wild- 
type  HA2  corresponding  to  a  molecular weight  difference 
1,000-2,000.  Similar alterations in mobility have been ob- 
served when single amino acid changes have been introduced 
into  small  proteins  such  as  p21  ras (30,  42)  or  subtilisin 
(Wells,  J., personal communication). Alternatively, it is pos- 
sible that these mobility differences might reflect minor alter- 
ations in the addition of terminal sugars to the single oligo- 
saccharide side chain on HA2. To investigate this possibility, 
wild-type and mutant HAs were isolated from vector infected 
cells labeled for 10 min so as to permit core glycosylation but 
not terminal glycosylation, or from cells labeled in the pres- 
ence of tunicamycin (46) to prevent any core glycosylation of 
HA. When the [35S]methionine-labeled HAs were treated with 
trypsin before SDS PAGE, the HA2 bands had very similar 
mobilities (results not shown). This result indicated that the 
mobility differences were manifested only after terminal gly- 
cosylation had occurred.  It is noteworthy that in the three- 
dimensional structure of the HA molecule deduced by Wilson 
et al. (51), the single oligosaccharide chain attached to aspar- 
agine residue  154 in HA2 is situated adjacent to the fusion 
peptide. 
Fusion Activities of  Mutant HAs 
We have previously shown that CV-t  cells that express HA 
on their plasma membranes can be induced to fuse with each 
other (48) or with RBCs (6) after a brief exposure to low pH; 
15  Gething et al. Mutagenesis of the Fusion Peptide of  HA Figure  3.  Comparison of wild-type and mutant HA proteins by SDS PAGE. CV- 1 cells infected for 36 h with recombinant SV40-HA virus 
stocks were labeled with [35S]methionine for 15 min. The cells were then washed and incubated in medium containing  an excess of nonradioactive 
methionine for 2 h to allow expression of the labeled wild-type or mutant proteins on the cell surface. The intact monolayers were then treated 
for 15 min at 37"C with DME (-) or DME containing 5 mg/ml trypsin (+) before cell extracts were prepared and analyzed by immunoprecip- 
itation and SDS PAGE as described in Materials and Methods. 
polykaryon formation appears to require more HA molecules 
per cell than does RBC-cell fusion (White,  J.,  unpublished 
observations). We have used both types of fusion assays to 
monitor the  effects of substitutions  of amino  acids  in  the 
fusion peptide. 
To analyze the ability of the mutant HAs to elicit RBC-cell 
fusion,  CV-I  cells  infected  with  the  various  recombinant 
viruses were treated  with  trypsin,  and  human  erythrocytes 
loaded with HRP were allowed to bind to the cells.  The pH 
was then transiently decreased to values between 4.8 and 5.6. 
Fusion-mediated delivery of  the RBC contents into CV-1 cells 
was monitored by staining fixed cells with DAB, or by mea- 
suring peroxidase activity in cell extracts. The results of these 
experiments are illustrated as light micrographs of fixed and 
stained cells in Fig. 4, and shown graphically in Fig.  5. HRP 
delivery into cells expressing the wild-type HA followed a pH 
dependence identical to that reported previously for fusion of 
baby hamster kidney cells  by the Japan strain  of influenza 
virus (49,  50).  The threshold  pH for fusion  was ~5.3,  and 
delivery of HRP into 50% of cells occurred at pH 5.1. At pH 
4.8,  80-90%  of the  cells  had  received HRP.  Cells that ex- 
pressed  the  M ll  mutant  HA  showed  an  almost  identical 
profile, which  indicated  that  replacing the glutamic acid at 
position 11 with glycine had no effect on the pH-dependence 
or efficiency of RBC-cell fusion.  By contrast,  both the  pH 
profile and efficiency of RBC-cell fusion were altered for cells 
expressing the M4 HA (glycine4 to glutamic acid). The thresh- 
old pH for RBC-cell fusion was elevated to approximately pH 
5.7. Maximum fusion was obtained at pH 5.3, with -45% of 
the  cells  showing cytoplasmic staining with  DAB.  The  M1 
mutation (glycine~ to glutamic acid) had the striking effect of 
abolishing the fusion activity of HA; cells expressing the M 1 
mutant protein showed little or no DAB staining at any pH, 
even though they bound RBCs as efficiently as the cells that 
expressed wild-type HA. Finally, the RBC-cell fusion charac- 
teristics of the M I/I 1 and M4/11  double mutants resembled 
those of the  M 1 and M4 parents. Thus the secondary M11 
mutation apparently contributed little to the RBC-cell fusion 
phenotype. 
To quantitate  directly the  amount  of HRP enzyme that 
had been delivered at pH 5.0 into cells expressing the mutant 
and  wild-type HAs,  it  was  necessary to  remove the  HRP- 
loaded  erythrocytes that  were bound  to  the  infected  CV-I 
cells  but  had  not  undergone  the  fusion  reaction.  This was 
achieved  using  neuraminidase,  and  then  cell extracts  were 
prepared and cell-associated HRP activity was measured using 
a spectrophotometric assay. The results summarized in Table 
I resemble those obtained by counting stained cells  (Fig.  5). 
Mutants  M1  and  M1/ll  lacked any  fusion  capability; the 
fusion activities of M4 and M4/11  were ~60%  of the wild- 
type level and that of the M11  mutant was -90% of the wild- 
type activity. 
In a parallel study using polykaryon formation as an assay 
for the HA-mediated membrane fusion, cells expressing the 
The Journal of Cell Biology, Volume 102, 1986  16 Figure 4.  Low pH-induced fusion of RBCs with CV- 1 ceils expressing wild-type  or mutant HA glycoproteins.  CV- 1 cells that had been infected 
for 54 h with SV40-HA recombinant vectors containing wild-type or mutant HA genes were treated with trypsin to cleave cell-surface HA into 
HAl and HA2 subunits. Human erythrocytes loaded with  HRP were bound to the cells and then the pH of the medium was transiently 
decreased to 5.6, 5.3, or 5.0. After incubation in culture medium for 45 min the cells were fixed with glutaraldehyde and stained with DAB to 
identify CV-I cells that had fused with HRP-loaded erythrocytes. Bar,  100 tzm. 
wild-type or mutant HAs were treated with trypsin to activate 
HA, and then the pH was transiently decreased to 5.6, 5.3, or 
5.0 (see Materials and Methods). The cells were then returned 
to normal medium and incubated for several hours to facili- 
tate  visualization  of polykaryon formation.  Representative 
light micrographs of cells from such an experiment are shown 
in  Fig. 6. The results obtained with cells expressing the  M1 
and M4 mutant HAs paralleled those seen in RBC-cell fusion 
assays. The M1  HA induced no polykaryon formation at any 
pH (data not shown), a  result consistent with the inability of 
M l to mediate HRP delivery. Cells expressing the M4 mutant 
fused  with  a  higher pH  threshold (pH  5.6).  Approximately 
50%  fusion was achieved at pH  5.3,  but the level of fusion 
was  not  further  increased  at  lower  pH  values.  The  most 
surprising result was obtained with  cells that expressed the 
M I 1 mutant.  M l 1 HA could not induce polykaryon forma- 
tion at or above pH 5.0, despite being able to mediate RBC- 
cell fusion with the same pH profile and efficiency as wild- 
type HA.  Further experiments at  even  lower pH  (data not 
shown)  revealed  that  very  limited  polykaryon  formation 
(~10%) could be induced by M11  HA at pH 4.6 or 4.4 (the 
lowest pH at which the assay could be performed). The fact 
that the M4/11 double mutant HA also lacked cell-cell fusion 
activity at pH 5.0 (data not shown) indicated that the amino 
acid alteration in M 11  was dominant in preventing polykar- 
yon formation. As expected, the combination of the M 1 and 
M l 1 mutations, which individually abolished cell-cell fusion 
activity at pH 5.0, resulted in a  double mutant that induced 
no polykaryon formation. 
Effect of the Mutations on the Conformational 
Change in HA 
The HA trimer has been shown to undergo a conformational 
change under the conditions that trigger membrane fusion (5, 
44). The change, which is irreversible, exposes a hydrophobic 
domain  in  HA2  which  is  probably  the  highly  conserved 
amino-terminal peptide of HA2 (3). A water-soluble fragment 
of HA, termed BHA, undergoes a conformational change that 
is indistinguishable from that observed in intact HA but more 
convenient to study in detail (5). 
A  consequence of the low pH-induced conformational al- 
teration  is  that  the  BHA  molecule,  which  is  resistant  to 
protease  at  neutral  pH,  becomes  sensitive  to  digestion  by 
proteinase K. The pH dependence of the protease sensitivity 
parallels that of the  fusion activity (5).  To determine if the 
alterations at the amino-terminus of HA2 affected either the 
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Figure 5.  pH profiles of RBC-cell fusion induced by wild-type and 
mutant HA proteins. CV- 1 cells were infected with SV40-HA vectors 
containing the wild-type or mutant HA genes. 54 h  after infection, 
the cells were treated with trypsin and tested at different pH values 
for their ability to fuse with HRP-loaded erythrocytes. The cells were 
then fixed with glutaraidehyde, stained with DAB, and scored for the 
extent of fusion as described in Materials and Methods. 
extent  or  pH  dependence  of the  conformational  change, 
[35S]methionine-labeled BHA was purified, treated at low pH, 
reneutralized,  and then incubated with proteinase K  before 
determination of the quantity of TCA-precipitable radioactiv- 
ity. The results of these experiments are shown in  Fig.  7A. 
Conversion of the  wild-type BHA  to the  protease-sensitive 
form was first detected after treatment at pH  5.8  and  was 
essentially complete at pH 4.8.50%  conversion of the BHA 
was obtained after incubation at pH 5.2, which is 0.1 pH unit 
higher  than  the  midpoint  of HA-induced  fusion  (Fig.  5). 
Analysis of the BHA by SDS PAGE demonstrated that both 
HA 1 and HA2 were digested and that after protease treatment 
following incubation  for  30  min  at  pH  4.8,  >80%  of the 
[35S]methionine  in  BHA  became TCA  soluble.  All  of the 
mutant proteins were resistant to protease at neutral pH and 
could  undergo  the  conformational  change,  with  maximal 
protease sensitivity achieved after incubation at pH 4.8.  The 
protease sensitivity of the MI 1 and MI/ll  BHAs followed 
the same pH profiles as those of the wild-type protein. The 
conformational change in the M4 and M4/11 BHAs occurred 
more  readily  than  that  in  the  wild-type  protein.  The  pH 
profiles  of protease  sensitivity  were  shifted  0.3  U  in  the 
alkaline direction;  50%  of the mutant BHA molecules con- 
verted to the sensitive form after treatment at pH 5.5. Finally, 
the conformational change in M 1 BHA occurred at lower pH 
than in the wild-type, since the protease sensitivity profile was 
shifted 0.2 pH U in the acid direction. 
Lipid Binding Properties of Wild-type and 
Mutant BHAs 
A second consequence of  the low pH-induced conformational 
change  in  BHA  is that  the  molecule acquires amphiphilic 
properties (5, 44). As a result the fragment will bind to other 
amphiphiles, such as nonionic detergents and artificial lipid 
bilayers.  Having  determined  that  both  the  wild-type  and 
mutant BHAs could undergo a low pH-induced conforma- 
tional change, we assessed the capacities of the proteins to 
bind to liposomes during incubation in solutions of various 
pH. After neutralization, the extent of  binding was determined 
Table I.  Relative Fusion EJficiencies at pH 5.0 of Wild-type 
and Mutant HAs 
HA protein expressed  Cell-associated HRP activity after  No. of determi- 
by CV-1 cells  RBC-cell fusion at pH 5.0*  nations 
Wild-type HA  1.00  4 
M I HA  0.04 +  0.02  2 
M4 HA  0.64 ___ 0.09  3 
MII HA  0.91  ___ 0.11  4 
MI/I 1 HA  0.07 _+_ 0.04  3 
M4/II HA  0.58 +-- 0.16  4 
* CV-1 cells were infected for 48 h with SV40-HA vectors expressing wild-type 
or mutant HA genes, treated with trypsin, and allowed to bind RBCs that had 
been preloaded with HRP. The cells were treated for 1 min with PBS buffered 
to pH 5.0 and then incubated for 1 h in normal tissue culture medium. Bound, 
but not fused,  RBCs were removed  using neuraminidase,  cell extracts were 
prepared, and cell-associated HRP activity was determined  using a spectropho- 
tometric  assay (see Materials and Methods  and reference 46). Activity levels 
are shown relative to the wild-type value. 
using flotation gradients. The results are shown in Fig.  7 B. 
The  extent  of binding  of the  various  BHAs to  liposomes 
varied with pH in a manner identical to that observed for the 
protease sensitivity of each molecule. 
We have previously demonstrated that the association of 
BHA (from the  X31  strain of influenza) with  liposomes is 
hydrophobic in nature (5).  Once bound, the protein cannot 
be removed by high or low salt, chaotropic agents, or urea. It 
can,  however, be eluted by elevated pH (>10.5).  The wild- 
type and mutant BHAs originating from the Japan strain of 
virus (Table II) showed identical characteristics in their inter- 
action  with  lipid  bilayers. Once bound  to liposomes, these 
BHA molecules could be removed only by treatment at high 
pH. All the molecules could rebind to lipid when returned to 
neutral pH. Thus we could not detect any differences in the 
nature of the interaction with liposomes of the wild-type or 
the mutant proteins. 
Kinetics of the Conformational Change in BHA 
To investigate the kinetics of development of protease sensi- 
tivity  and  liposome  binding  capacity,  trace  quantities  of 
[35S]methionine-labeled BHAs were incubated with liposomes 
at pH 4.8  for various times at 37"C. Aliquots were removed 
and tested for protease sensitivity or lipid binding as described 
above. In Fig.  8 we display the results for the wild-type and 
the M1  and M4 mutant BHAs. For the wild-type, M4 and 
M 11  molecules, the kinetics of conversion to protease sensi- 
tivity  closely  parallels  those  of acquisition  of amphiphilic 
character. M11  BHA showed the same kinetics as the wild- 
type, with  50%  of the maximal values reached 2 min after 
acidification. M4 BHA converted to the low pH form more 
rapidly. M 1 BHA was the only protein that displayed different 
kinetics for protease sensitivity and lipid binding. Compared 
with the wild-type BHA, M 1 displayed a slower rate of con- 
version to  protease sensitivity, and  an even  slower rate  of 
interaction with lipid, suggesting that its mode of interaction 
with the target bilayer may be altered from that of the wild- 
type HA or the other mutant proteins. 
Discussion 
In past studies, enveloped viruses have been useful probes for 
many dynamic aspects of biological membranes such as re- 
ceptor-mediated endocytosis (reviewed in reference  14) and 
The Journal  of Cell Biology, Volume  102, 1986  18 Figure  6.  Low pH-induced polykaryon formation of CV-1  cells expressing wild-type or mutant HA proteins. CV-I cells were infected with 
SV40-HA vectors containing the wild-type or mutant HA genes. 60 h after infection, the cells were treated with trypsin then tested at different 
pH values for their ability to fuse to form polykaryons  (see Materials and Methods). The cells were then fixed and photographed. Bar, 100 ttm. 
the biosynthesis,  assembly,  and intracellular transport of in- 
tegral membrane proteins (see for example references  18, 24, 
36, and 43).  Similarly,  in  recent years,  the fusion reactions 
that mediate infections by such viruses have increasingly been 
used as models of cellular membrane fusion events (reviewed 
in reference  49). 
Although fusion between lipid  bilayers  is undoubtedly an 
extremely complex event  in  molecular terms,  every fusion 
reaction can be considered in three simple  stages: close ap- 
proach of the interacting membranes, lipid  layer destabiliza- 
tion, and reformation of one united bilayer.  Since two mem- 
branes experience an exponentially increasing repulsive  force 
as they approach closer than ~20 A (33), the first  phase of 
any membrane fusion event is energetically  highly unfavora- 
ble.  Mechanisms must therefore exist  to overcome this for- 
midable obstacle before two bilayers  can fuse. Our previous 
work has  suggested  how the  HA glycoprotein of influenza 
virus may facilitate the first phase of fusion by binding firmly 
and  simultaneously to both  of the fusing  membranes (48). 
The interaction with the virus or host cell membrane involves 
the hydrophobic transmembrane "anchor" near the carboxy- 
terminus  of the  HA  polypeptide; the  interaction  with  the 
target membrane involves the highly conserved apolar peptide 
at the amino-terminus of the HA2 subunit,  which becomes 
exposed only at low pH (3, 5, 44). 
Recent  studies  of variant  influenza viruses  that  mediate 
fusion  at  elevated  pH  values  have  identified  amino  acid 
residues in the HA molecule that stabilize the structure of HA 
at neutral pH (4, 5a, 38). Substitution of  these residues appears 
to lower the energy barrier necessary for the low pH-induced 
conformational transition to the fusion-active state.  Some of 
these  residues  were  located along the interface between the 
individual subunits of the HA trimer (4, 5a), whereas  others, 
including three amino acids located within the fusion peptide, 
stabilized  the unexposed location of the amino-terminus of 
HA2 (4, 38). It was notable that unlike most of the mutated 
residues  analyzed in the variant HAs, the three amino acids 
located  in  the  fusion  peptide  had  undergone conservative 
substitutions; none had been altered to charged amino acids 
(4).  This  may  have  been  a  consequence  of the  selection 
procedures used; the population of variant viruses would not 
by definition include mutant viruses that could not carry out 
the fusion reaction at any pH. Thus, a different  strategy was 
necessary to produce and characterize mutant HAs that might 
be  inactive  or disabled  for fusion  instead  of or  as  well  as 
altered in their pH dependence. In an attempt to find such 
mutants and to probe the consequences of altering the hydro- 
phobicity and  length  of the  fusion  peptide,  we  have  con- 
structed  and  characterized  five  genetically  engineered  HA 
molecules that contain specific, nonconservative amino acid 
changes in the fusion peptide. 
Oligonucleotide-directed mutagenesis  was  used  to  intro- 
duce single nucleotide changes into a cloned copy of the gene 
encoding the HA from the A/Japan/305/57 strain of influ- 
enza virus.  The amino acid alterations that were introduced 
are shown in Fig.  1, and the rationale for our choices was as 
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Figure  7.  pH dependence of protease sensitivity and liposome bind- 
ing capacity of wild-type and mutant BHAs. [35SlMethionine-labeled 
BHAs were  prepared  as described  in  Materials  and  Methods.  For 
determination of the pH dependence of conversion to sensitivity to 
digestion  with  protease,  the  labeled  BHAs  were  incubated  at  the 
indicated pH for 30 min at 37°C, neutralized, and digested with 0.1 
mg/ml proteinase K  before analysis of the quantity of TCA-precipi- 
table  radioactivity.  For  determination  of the  pH  dependence  of 
acquisition of liposome binding capacity, the BHAs were incubated 
in the presence of liposomes at the indicated pH for 30 min at 37°C, 
after which the solution was neutralized and centrifuged on a flotation 
gradient to determine the amount of lipid-bound protein. 
Table  II.  Effect of High Salt and High pH on the Binding 
of  BHAs to Liposomes 
% BHA  % BHA re- 
% BHA bound  eluted  % BHA  bound after 
to lipid after 30  by 1 M  eluted at  shift from pH 
min, pH 4.8  KCI  pH 11  11 to pH 7 
Wild-type BHA  78  7  58  100 
MI  BHA  57  14  65  108 
M4 BHA  79  8  63  97 
MII  BHA  79  10  58  104 
MI/II  BHA  70  12  62  88 
M4/11  BHA  87  10  ND  ND 
~SS-methionine labeled  BHAs were incubated with liposomes at pH 4.8 for 30 
rain at 37"C. The solutions were then neutralized and divided into four aliquots, 
one of which was assayed immediately for liposome binding as described  in 
Fig. 7. The remaining aliquots were treated with either salt or base as follows 
before the amount of lipid-associated  protein was determined. 4 M  KCI was 
added to one aliquot to bring the final salt concentration to I M. This solution 
was incubated for 15 min at 37"C before centrifugation on a flotation gradient 
that also contained 1 M KCI. After the remaining two aliquots were incubated 
at pH  11  for  15 min, one was assayed for lipid-bound protein in a gradient 
maintained at pH 11 .The final aliquot was returned to pH 7 for 15 min before 
being assayed for  lipid  binding in  a  flotation  gradient at  pH  7.  ND,  not 
determined. 
follows. In the neutral conformation of the HA molecule, the 
fusion peptide is tucked into the interface between the sub- 
units of the trimer. The amino nitrogen  of residue  1 (Gly) 
and the amide nitrogens of residues 4,  5, and 6 (Gly.Ala.Ile) 
of HA2 form hydrogen bonds to oxygen atoms of residue 112 
(Asp) in the long helix of HA2 (4, 51). Substitution ofglutamic 
acid for glycine residues at positions  1 and 4  (mutants M 1 
and M4) introduces negative charges into the fusion peptide 
which might disrupt the normal hydrogen bonding interac- 
tions.  In  the  second  instance,  the  M4  substitution  would 
significantly shorten the stretch of apolar amino acids.  In the 
Japan  HA2  subunit,  the stretch of hydrophobic residues is 
terminated by a glutamic acid residue at position 11. Substi- 
tution of this amino acid by a glycine (mutant M11) extends 
the apolar sequence to  18 residues until the aspartic acid at 
position  19,  permitting additional testing of the role played 
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Figure  8.  Kinetics of conversion to protease  sensitivity  and liposome 
binding capacity. [35S]Methionine-labeled BHAs, purified from cells 
expressing wild-type or mutant HA proteins, were mixed with lipo- 
somes at  37"C.  The  solutions were  acidified  to  pH  4.8,  and  then 
aliquots were  removed at the times shown, neutralized,  and either 
treated with  proteinase K  to determine the extent of conversion to 
the protease-sensitive form (open symbols) or centrifuged in flotation 
gradients to  determine  the  amount of lipid-bound  protein  (closed 
symbols). 
by the length of the hydrophobic sequence.  The role of the 
positioning of the hydrophobic sequence was tested by con- 
structing the double mutants (Glu~/Glyj~  (M1/11) and Glu4/ 
Glyl~ (M4/11) which contain internal apolar stretches of 17 
or 14 residues, respectively. 
The wild-type and mutant genes were expressed in simian 
cells using SV40-based vectors, and the HA molecules were 
assayed for fusion activity and for the ability to undergo the 
characteristic low pH-induced conformational change. The 
results of these experiments are summarized in Table III. The 
wild-type HA protein  undergoes a  rapid conversion at low 
pH into a conformation that can interact with lipid and that 
is sensitive to degradation with protease. Concomitant with 
this conformational change, which occurs at a characteristic 
pH threshold, wild-type HA expressed on the surface of a CV- 
1 cell  can mediate fusion either between the CV-1  cell  and 
RBCs, or between adjacent CV-1  cells to form polykaryons. 
This fusion occurs with high efficiency; at pH 5.0,  >90% of 
the CV- 1 cells expressing the wild-type protein fuse with target 
lipid bilayers. Examination of the results obtained with the 
mutant HA proteins reveals three different fusion phenotypes 
and  provides  insights  into  the  roles  of HA  in  the  fusion 
reaction. 
M1 HA 
The substitution of a glutamic acid for the glycine residue at 
the amino-terminus of the fusion peptide abolished all of the 
fusion activity of the HA protein. However, this protein could 
still undergo a conformational change at low pH that resulted 
in protease sensitivity and lipid binding capability. The lower 
pH at which this conformational change occurred, and the 
greater time taken at pH 4.8 for the conversion to be mani- 
fested, suggested that the mutation had in some way stabilized 
a  neutral  conformation  of the  protein.  However, once the 
mutant protein became bound to liposomes, its interaction 
with lipid had the same characteristics as that of the wild-type 
protein. This result makes it unlikely that the mutant protein 
is interacting in a  nonspecific fashion with the lipid bilayer 
and suggests  that the binding of HA to both membranes is 
necessary  but  not  sufficient  for  fusion  to  occur.  Thus  it 
appears that HA may play an additional role in destabilization 
of the lipid bilayer during fusion. 
The Journal of Cell Biology, Volume 102, 1986  20 Table  IlL  Summary of the Fusion Phenotypes of the Wild-type and Mutant HA Proteins 
Time at pH 4.8 for 50% conversion 
Efficiency at pH  Efficiency  at pH  pH at which 50% of BHA is 
Threshold pH of  Threshold pH of  5 of RBC-cell fu-  5 of cell-cell fu-  converted to protease sensitiv-  To protease  To lipid 
RBC-cell fusion  cell-cell fusion  sion  sion  ity and lipid binding  sensitivity  binding 
%  %  rain  min 
WT  5.3  5.3  90  90  5.3  3  3 
MI  --  --  0  0  5.0  6  16 
M4  5.7  5.6  50  50  5.5  1  1 
MI 1  5.3  4.6  90  0  5.3  3  3 
MI/ll  --  --  0  0  5.3  ND  ND 
M4/11  5.7  4.6  50  0  5.5  ND  ND 
These values are summarized  from the data  shown in Figs. 5-8.  The experimental  details are given in the figure legends and in Materials and Methods. --, no 
fusion detected at any pH tested, ND, not determined. 
M4 HA 
The substitution of a glutamic acid for the glycine residue at 
position 4 of the fusion peptide (which decreases the length 
of the apolar stretch to six amino acids) accelerated the rate 
and  raised the threshold  pH at which the  low pH-induced 
conformational change occurred in the mutant protein. Thus, 
the mutation  had destabilized the  neutral  conformation of 
HA in a similar fashion to the amino acid alterations identi- 
fied in the variant viruses selected in previous studies (4, 5a, 
38). The raised pH threshold for the conformational change 
was reflected in a  raised pH threshold for RBC-cell or cell- 
cell fusion. However, the fusion mediated by this mutant HA 
never became as  efficient  as  that  caused  by the  wild-type 
protein; even at pH <5.0 only 50% fusion was observed. This 
result suggests that the amino acid at position 4 in HA2 may 
play two  roles-a structural  role  in  maintaining  the  fusion 
peptide in its neutral conformation (4) and another role in 
the  lipid  destabilization  phase  of fusion.  Whether  the  de- 
creased efficiency of fusion is a  direct result of the specific 
substitution at position 4 in the fusion peptide or whether it 
is  a  consequence  of interruption  of the  stretch  of apolar 
residues by a  charged amino acid remains to be tested. No 
HA molecules isolated from fusion-active influenza viruses 
(either  naturally  occurring  "wild-type" influenza  A  viruses 
(21) or fusion variants [4]) contain polar residues within the 
fusion peptide, perhaps because variants such as M4 would 
be at a competitive disadvantage during infection as a result 
of their  reduced  fusion  activity.  Unfortunately,  we  are  at 
present unable to convert the mutated HA cDNAs into viral 
RNA  genes and  thus  cannot  assay the  ability of influenza 
virions  containing  M4  HA  to  enter  the  cell  and  mediate 
infection. 
Mll  HA 
Substitution of a glycine residue for the glutamic acid residue 
at  position  11  of HA2  (which  increases the  length  of the 
hydrophobic sequence to  18 amino acids) had no effect on 
the rate or pH dependence of the conformational change in 
the  mutant protein.  This observation is consistent with the 
location of  this residue on the external surface of  the molecule, 
distant from the trimer interface or the "hinge region" (51). 
Neither did the mutation have any positive or negative effect 
on the initial binding of the protein to the target lipid bilayer, 
suggesting that the length of the apolar sequence is not critical 
for this interaction. Furthermore, the mutant protein induced 
RBC-cell fusion with the same pH dependence and efficiency 
as wild-type HA. However, the M 11 HA was greatly impaired 
in mediating cell-cell fusion. This phenotype provides the first 
instance of a  distinction  between RBC-cell fusion and cell- 
cell fusion. The M11  HA is competent to mediate fusion of 
the CV- 1 and erythrocyte cell membranes over the small areas 
necessary for injection of HRP into the CV- 1 cytoplasm, but 
except at very low pH it appears to be unable to cause lipid 
bilayer destabilization over areas sufficient to allow polykar- 
yon formation. It should be noted that the localized fusion 
that occurs between erythrocytes and cells (6) may be a better 
model for the  infection of cells by fusion  of the influenza 
virus envelope and the endosome membrane (28,  49) than is 
the extensive membrane coalescence that is assayed by poly- 
karyon formation. 
M1/ll  and M4/ll  HAs 
Analysis of the phenotypes of the proteins that contain double 
mutations confirmed our conclusions that the conformational 
change in HA and the subsequent interaction of the protein 
with the target bilayer are separate events from the bilayer 
destabilization that results in  membrane fusion.  When  two 
amino acid substitutions are present in the HA molecule, the 
conformational change and lipid-binding phase of the fusion 
reaction is dominated by the mutation that destabilizes the 
native  protein  structure,  causing the  threshold  pH  for the 
conversion to be raised. By contrast, the mutation that dom- 
inates  the  membrane fusion  phase  of the  reaction  is  that 
which shows the most deleterious effects in the single mutants. 
Thus, in the M1/11 double mutant, the M11 alteration influ- 
ences the  pH at  which  the  conformational change occurs, 
whereas the M I substitution dominates in abolishing fusion 
activity. On the other hand, in the M4/11 double mutant the 
M4  substitution  influences the  conformational change and 
the pH threshold for RBC-cell fusion whereas the M11 alter- 
ation  dominates in  preventing cell-cell  fusion.  The  double 
mutants also provide evidence that the length and positioning 
of the apolar stretch of amino acids at the amino terminus of 
HA2 are not critical for fusion. 
Summary 
In summary, the mutations that we have introduced into the 
fusion  peptide of HA have allowed  us to delineate several 
stages of the mechanism of HA-mediated membrane fusion. 
These  stages  include  the  low  pH-induced  conformational 
change in HA that exposes the fusion peptide; the interaction 
of  the fusion peptide and/or other regions of  the HA molecule 
with the target lipid bilayer; destabilization of the lipid bilayer 
and membrane coalescence over small areas, and membrane 
21  Gething et al. Mutagenesis ~f  the Fusion Peptide of HA coalescence  and  separation  over  large  areas,  resulting  in 
polykaryon formation.  The  M1  mutant  provides  the  first 
opportunity  to  separate  temporally  the  conformational 
change from lipid binding; in all previous studies these events 
have  appeared  to  occur  simultaneously  (5,  44).  The  M1 
mutant also allows separation of the lipid binding and bilayer 
fusion stages of the process,  which indicates that  HA  does 
more than simply bring the two membranes close together. It 
is  possible  that  the  fusion  peptide  must  assume  a  precise 
structure in the target membrane in order to cause sufficient 
destabilization to promote fusion. Finally, the M ll  mutant 
provides evidence that HA may also play a role in propagation 
of fusion over large areas of membrane--a role that is mani- 
fested in the in vitro assay systems but not during infection 
in vivo. 
Although this study has provided insights into the sequence 
of events that lead to fusion, the molecular details of HA's 
role  in  the  fusion  mechanism  remain  to  be  elucidated. 
Whereas it is possible to use the known three-dimensional 
structure of the neutral form of HA (5 l) to interpret the role 
of individual amino acid substitutions that affect the conver- 
sion of the protein into the low pH conformation, it is difficult 
to interpret the effect of substitutions that affect bilayer de- 
stabilization because we as yet have no detailed knowledge of 
the structure of the low pH  form of HA  before or after it 
interacts with  the  target  membrane.  Furthermore, we  cur- 
rently have no evidence as to whether this interaction involves 
solely the fusion peptide, or whether other portions of the HA 
molecule (such as the amphipathic region at the top of the 
long alpha-helix of HA2) may also bind to the lipid bilayer. 
Further mutants with site-directed alterations in this region 
could be constructed to test this hypothesis.  We  hope that 
future experiments that combine the power of recombinant 
DNA  techniques  with  the  elegance  of  the  model  system 
provided by influenza HA  will reveal  further details  of the 
molecular mechanism of HA-induced fusion. The availability 
of cloned copies of other viral fusion proteins (1, 20,  31,  34, 
37) should now permit similar analyses in other virus systems. 
Such studies should reveal both the common and the unique 
features of the mechanisms by which these proteins mediate 
membrane fusion. 
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